TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia (TREATT)
A Double-blind, Randomised Controlled Trial Evaluating the Safety and Efficacy of Antifibrinolytics (Tranexamic Acid) in Patients With Haematological Malignancies With Severe Thrombocytopenia
Sponsor: Monash University
Listed as NCT03136445, this PHASE3 trial focuses on Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation and remains completed. Sponsored by Monash University, it has been updated 16 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
16 versions recorded-
Nov 2025 — Present [monthly]
Completed PHASE3
-
Jan 2025 — Nov 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 11 earlier versions
-
Jul 2022 — Dec 2023 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Oct 2021 — Jul 2022 [monthly]
Recruiting PHASE3
-
Apr 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Dec 2019 — Mar 2020 [monthly]
Recruiting PHASE3
-
Jan 2019 — Dec 2019 [monthly]
Recruiting PHASE3
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jun 2017 — Oct 2017 [monthly]
Recruiting PHASE3
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Monash University
- NHS Blood and Transplant
- National Health and Medical Research Council, Australia
For direct contact, visit the study record on ClinicalTrials.gov .